Overview
- Carmat announced cessation of payments on June 30 and applied to the Versailles Economic Court to open judicial restructuring proceedings.
- The company requested suspension of its stock trading from June 30 as its share price collapsed from over €100 to around €0.30.
- Despite launching a public donation campaign on June 20, Carmat failed to secure the €3.5 million needed by June 30 or the €20 million aimed for year-end.
- The firm employs 180 staff across Vélizy-Villacoublay and Bois-d’Arcy and continues to pursue investors and government backing to sustain its operations.
- Carmat says it will continue device support for 122 patients implanted with its Aeson artificial heart throughout the restructuring process.